35 related articles for article (PubMed ID: 1495578)
1. Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice.
Quandt JA; Baig M; Yao K; Kawamura K; Huh J; Ludwin SK; Bian HJ; Bryant M; Quigley L; Nagy ZA; McFarland HF; Muraro PA; Martin R; Ito K
J Exp Med; 2004 Jul; 200(2):223-34. PubMed ID: 15263029
[TBL] [Abstract][Full Text] [Related]
2. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
Muraro PA; Vergelli M; Kalbus M; Banks DE; Nagle JW; Tranquill LR; Nepom GT; Biddison WE; McFarland HF; Martin R
J Clin Invest; 1997 Jul; 100(2):339-49. PubMed ID: 9218510
[TBL] [Abstract][Full Text] [Related]
3. HSP70-1 promoter region polymorphism tested in three autoimmune diseases.
Cascino I; Galeazzi M; Salvetti M; Ristori G; Morozzi G; Richiardi PM; Tosi R
Immunogenetics; 1994; 39(4):291-3. PubMed ID: 8119737
[No Abstract] [Full Text] [Related]
4. HLA antigens in multiple sclerosis of northern Spanish population.
López-Larrea C; Uría DF; Coto E
J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis in the Faroe Islands. VI. Studies of HLA markers.
Jersild C; Kurtzke JF; Riisom K; Heltberg A; Arbuckle J; Hyllested K
Tissue Antigens; 1993 Aug; 42(2):105-10. PubMed ID: 7903488
[TBL] [Abstract][Full Text] [Related]
6. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis.
Marrosu MG; Muntoni F; Murru MR; Spinicci G; Pischedda MP; Goddi F; Cossu P; Pirastu M
Neurology; 1988 Nov; 38(11):1749-53. PubMed ID: 2903464
[TBL] [Abstract][Full Text] [Related]
7. HLA and multiple sclerosis in south east Wales.
Swingler RJ; Kirk PF; Darke C; Compston DA
J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1153-5. PubMed ID: 3499485
[TBL] [Abstract][Full Text] [Related]
8. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland.
Francis DA; Batchelor JR; McDonald WI; Dodi IA; Hing SN; Hern JE; Downie AW
Tissue Antigens; 1987 Jan; 29(1):7-12. PubMed ID: 3590146
[TBL] [Abstract][Full Text] [Related]
9. HLA determinants in familial multiple sclerosis.
Grasso MG; Cutrupi F; Bernardi S; Trabace S; Pozzilli C; Cappellacci S; Fieschi C
Neuroepidemiology; 1992; 11(2):85-9. PubMed ID: 1495578
[TBL] [Abstract][Full Text] [Related]
10. [HLA and multiple sclerosis. Studies of a spanish population].
Uría DF
Rev Neurol; 2000 Dec 1-15; 31(11):1066-70. PubMed ID: 11190875
[TBL] [Abstract][Full Text] [Related]
11. HLA and rheumatoid arthritis: an analysis of multicase families.
Ollier W; Silman A; Gosnell N; Currey H; Awad J; Doyle P; McCloskey D; Alonso A; Hossain MA; Festenstein H
Dis Markers; 1986 Jun; 4(1-2):85-98. PubMed ID: 3330700
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA and multiple sclerosis.
Martin R; Vogt AB; Kropshofer H; Lichtenfels R
Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
